These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
995 related articles for article (PubMed ID: 17207788)
1. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788 [TBL] [Abstract][Full Text] [Related]
2. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P; Prigent AF; Lagarde M; Nemoz G Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [TBL] [Abstract][Full Text] [Related]
3. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices. Rutten K; Vente JD; Sik A; Ittersum MM; Prickaerts J; Blokland A Behav Brain Res; 2005 Oct; 164(1):11-6. PubMed ID: 16076505 [TBL] [Abstract][Full Text] [Related]
4. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. de Vente J; Markerink-van Ittersum M; Vles JS J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445 [TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats. Rutten K; Van Donkelaar EL; Ferrington L; Blokland A; Bollen E; Steinbusch HW; Kelly PA; Prickaerts JH Neuropsychopharmacology; 2009 Jul; 34(8):1914-25. PubMed ID: 19262466 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Ko WC; Shih CM; Lai YH; Chen JH; Huang HL Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679 [TBL] [Abstract][Full Text] [Related]
7. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task. Giorgi M; Modica A; Pompili A; Pacitti C; Gasbarri A Behav Brain Res; 2004 Sep; 154(1):99-106. PubMed ID: 15302115 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457 [TBL] [Abstract][Full Text] [Related]
10. Implications of PDE4 structure on inhibitor selectivity across PDE families. Ke H Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132 [TBL] [Abstract][Full Text] [Related]
11. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306 [TBL] [Abstract][Full Text] [Related]
12. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors. Uckert S; Bazrafshan S; Scheller F; Mayer ME; Jonas U; Stief CG Urology; 2007 Jul; 70(1):185-9. PubMed ID: 17656245 [TBL] [Abstract][Full Text] [Related]
13. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3. Beierwaltes WH Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359 [TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Prickaerts J; Sik A; van Staveren WC; Koopmans G; Steinbusch HW; van der Staay FJ; de Vente J; Blokland A Neurochem Int; 2004 Nov; 45(6):915-28. PubMed ID: 15312986 [TBL] [Abstract][Full Text] [Related]
15. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5. Dunkern TR; Hatzelmann A Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064 [TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors in airways disease. Fan Chung K Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289 [TBL] [Abstract][Full Text] [Related]
17. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue. Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats. Makhay MM; Houslay MD; O'Donnell JM Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620 [TBL] [Abstract][Full Text] [Related]
19. Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement. Hosseini-Sharifabad A; Ghahremani MH; Sabzevari O; Naghdi N; Abdollahi M; Beyer C; Bollen E; Prickaerts J; Roghani A; Sharifzadeh M Pharmacol Biochem Behav; 2012 May; 101(3):311-9. PubMed ID: 22306745 [TBL] [Abstract][Full Text] [Related]
20. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients. Weeks JL; Zoraghi R; Beasley A; Sekhar KR; Francis SH; Corbin JD Int J Impot Res; 2005; 17(1):5-9. PubMed ID: 15538396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]